Reducing Mortality in Patients with Advanced Cardiovascular Disease: Subgroups, Subgroups and More Subgroups…

By Saksena Sanjeev  

Journal of Interventional Cardiac Electrophysiology, Vol. 10, Iss. 1, 2004-02 ,pp. : 7-8

Springer Publishing Company

Access to resources Recommend Favorite

The effect of placebo adherence on reducing cardiovascular mortality: a meta-analysis

By Yue Zhao   Cai Cheng   Ai-fang Yang   Feng-min Tang   Li Chen   Bin Wang  

Clinical Research in Cardiology, Vol. 103, Iss. 3, 2014-03 ,pp. : 229-235

Springer Publishing Company

Access to resources Recommend Favorite

Is C-Reactive Protein a Reliable Risk Factor of Cardiovascular Morbidity and Mortality in Clinical Practice?

By Vernaglione Luigi   Nosella Viviana   Chimienti Stefano  

High Blood Pressure & Cardiovascular Prevention, Vol. 15, Iss. 3, 2008-01 ,pp. : 135-139

Adis International

Access to resources Recommend Favorite

Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study

By Brennan A.   Li T.   Kelesidis I.   Gavrila A.   Hu F.   Mantzoros C.  

Diabetologia, Vol. 50, Iss. 6, 2007-06 ,pp. : 1178-1185

Springer Publishing Company

Access to resources Recommend Favorite

Cardiovascular Disease Morbidity and Mortality in Patients with Type 1 Diabetes Mellitus: Management Strategies

By Soedamah-Muthu Sabita S.  

Treatments in Endocrinology, Vol. 4, Iss. 2, 2005-01 ,pp. : 75-86

Adis International

Access to resources Recommend Favorite